Within our project, sc-RNA seq analysis was employed to explore the heterogeneity of ECs throughout the initiation and progression of primary liver cancer, and identified a unique subset of tumor associated senescent CD34+CLDN5+ECs, which were mainly present in the tumor tissue. The gene discussed is CLDN5; the disease is liver cancer.